findmyKOL
Clinical trialNCT01102426CompletedPhase 3Interventional

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma

SponsorPharmaMarEnrollment255Relapsed/Refractory Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • 108

    Adelaide, Australia

  • 102

    Canberra, Australia

  • 101

    Geelong, Australia

  • 105

    Parkville, Australia

  • 106

    Perth, Australia

  • 104

    South Brisbane, Australia

  • 109

    Woodville, Australia

Austria
  • 202

    Graz, Austria

  • 204

    Innsbruck, Austria

  • 203

    Salzburg, Austria

  • 201

    Vienna, Austria

  • 205

    Vienna, Austria

  • 208

    Vienna, Austria

Belgium
  • 304

    Bruges, Belgium

  • 301

    Brussels, Belgium

  • 303

    Brussels, Belgium

  • 302

    Ghent, Belgium

Czechia
  • 502

    Brno, Czechia

  • 503

    Hradec Králové, Czechia

  • 501

    Prague, Czechia

France
  • 601

    Lille, France

  • 602

    Nantes, France

  • 606

    Rouen, France

  • 604

    Vandœuvre-lès-Nancy, France

Germany
  • 709

    Düsseldorf, Germany

  • 705

    Essen, Germany

  • 706

    Frankfurt, Germany

  • 707

    Frankfurt, Germany

  • 708

    Freiburg im Breisgau, Germany

  • 703

    Heidelberg, Germany

  • 702

    München, Germany

  • 704

    Würzburg, Germany

Greece
  • 1301

    Athens, Greece

  • 1303

    Pátrai, Greece

  • 1302

    Thessaloniki, Greece

Ireland
  • 1401

    Dublin, Ireland

Italy
  • 806

    Bari, Italy

  • 801

    Genova, Italy

  • 805

    Reggio Emilia, Italy

  • 803

    Rozzano, Italy

42 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2010
Primary completion
30 Nov 2017
Completion
30 Nov 2017
Last update posted
10 Nov 2020
Registered enrollment
255
Registry id
NCT01102426
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.